A Dose-exploration Study of EDP167 in HoFH

Clinical trial NCT07489209 · RECRUITING

Trial details

NCT number: NCT07489209
Sponsor: Eddingpharm (Zhuhai) Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Homozygous Familial Hypercholesterolemia (HoFH)

Start date: 2026-02-06
Primary completion: 2026-10-04
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.